Bessemer Group Inc Haemonetics Corp Transaction History

Bessemer Group Inc

$55.8 Billion
Q1 2025

A detailed history of Bessemer Group Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Bessemer Group Inc holds 141 shares of HAE stock, worth $10,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141

Previous 125 12.8%

Holding current value

$10,651

Previous $10,000 10.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	BUY	$59.34 - $80.05 $949 - $1,280	16 Added 12.8%	141 $9,000
Q4 2024 Feb 13, 2025	SELL	$71.16 - $93.38 $44,688 - $58,642	-628 Reduced 83.4%	125 $10,000
Q3 2024 Nov 12, 2024	BUY	$72.45 - $91.58 $14,562 - $18,407	201 Added 36.41%	753 $60,000
Q2 2024 Aug 13, 2024	BUY	$81.24 - $97.37 $41,838 - $50,145	515 Added 1391.89%	552 $46,000
Q1 2024 May 13, 2024	SELL	$71.24 - $85.35 $641 - $768	-9 Reduced 19.57%	37 $3,000
Q4 2023 Feb 09, 2024	SELL	$80.59 - $92.61 $3,384 - $3,889	-42 Reduced 47.73%	46 $4,000
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $3,797 - $4,300	46 Added 109.52%	88 $8,000
Q2 2023 Aug 10, 2023	BUY	$80.84 - $89.45 $3,395 - $3,756	42 New	42 $4,000
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $3.39 Million - $4.19 Million	-44,800 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$74.34 - $121.82 $126,378 - $207,094	1,700 Added 3.94%	44,800 $4.47 Million
Q4 2019 Feb 04, 2020	BUY	$114.37 - $129.46 $34,311 - $38,838	300 Added 0.7%	43,100 $4.95 Million
Q3 2019 Nov 07, 2019	BUY	$117.16 - $138.52 $105,444 - $124,668	900 Added 2.15%	42,800 $5.4 Million
Q2 2019 Jul 19, 2019	BUY	$81.74 - $120.34 $572,180 - $842,380	7,000 Added 20.06%	41,900 $5.04 Million
Q1 2019 May 13, 2019	BUY	$83.25 - $102.12 $83,250 - $102,120	1,000 Added 2.95%	34,900 $3.05 Million
Q4 2018 Feb 12, 2019	BUY	$90.66 - $116.63 $516,762 - $664,791	5,700 Added 20.21%	33,900 $3.39 Million
Q3 2018 Nov 06, 2018	SELL	$89.96 - $114.58 $53,975 - $68,748	-600 Reduced 2.08%	28,200 $3.23 Million
Q2 2018 Jul 25, 2018	SELL	$71.53 - $95.75 $178,825 - $239,375	-2,500 Reduced 7.99%	28,800 $2.58 Million
Q1 2018 May 10, 2018	SELL	$60.72 - $74.41 $406,824 - $498,547	-6,700 Reduced 17.63%	31,300 $2.29 Million
Q4 2017 Jan 30, 2018	SELL	$44.96 - $58.99 $930,672 - $1.22 Million	-20,700 Reduced 35.26%	38,000 $2.21 Million
Q3 2017 Nov 03, 2017	BUY	$40.38 - $44.87 $2.37 Million - $2.63 Million	58,700	58,700 $2.63 Million

Others Institutions Holding HAE

# of Institutions

350

Shares Held

53.2M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.88B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Haemonetics Corp Transaction History